Interestingly, Kim 19 first revealed that SPOCK1‐mediated EMT signalling conferred acquired resistance to lapatinib in human epidermal growth factor receptor 2 (HER2)‐positive gastric cancer. This evidence concerns the gene SPOCK1 and gastric cancer.